Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The investment case for health technology in India is frequently overstated in one direction and understated in another
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Revvity is positioning its technologies as a connected engine for discovery
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
The company allocated €56 million to research and development for next-generation line solutions
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
The company reported net revenue of SEK 13.5 million for the full year 2025
Subscribe To Our Newsletter & Stay Updated